The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The Federal Drug Administration approved Pradaxa, a blood-thinning drug, in 2010. Pradaxa reduces the risk of stroke and blood clots and initially was widely embraced by medical professionals. Within a few months of its release however, physicians and experts began to question its safety. The blood thinning effects reverse, and the drug can cause serious injuries and massive bleeding.

Pradaxa has been linked with as many as 256 deaths related to fatal bleeding, according to FiercePharma.com. The Committee for Medicinal Products for Human Use in the European Union issued a warning about the safety of the product.

In the United States, the FDA requires updated warnings on labels to inform the public of new developments or research. Often times these warnings are buried in legal jargon or fine print, but it’s important for consumers to be aware of the risks before they consume the drugs.

Have you or a loved one been injured by Pradaxa or another defective product?

Wooten, Kimbrough & Normand, P.A.—Orlando wrongful death attorneys.

Comments are closed.

Of Interest